A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects With Mild-to-Moderate Ulcerative Colitis
Clinical trial NCT02618187 · COMPLETED
Trial details
- NCT number
- NCT02618187
- Sponsor
- Seres Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-13
- Primary completion
- 2017-12-06
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.